Literature DB >> 20623125

Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis.

Alexandra Gonzalez Fuentes1, Ashwini Komarla, John I Gomez.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome that manifests with the onset of headache, confusion or decreased level of consciousness, visual changes, and seizures in conjunction with the typical neuroimaging features of posterior cerebral white matter changes, which are usually reversible. This syndrome has been associated with hypertension, eclampsia, renal insufficiency, immunosuppressive drugs, and connective-tissue diseases. To our knowledge, only four cases of PRES associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have been reported in the literature. Here, we present a patient with ANCA-associated vasculitis complicated by PRES.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623125     DOI: 10.1007/s00296-010-1367-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  6 in total

1.  Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis.

Authors:  A Primavera; D Audenino; N Mavilio; L Cocito
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 2.  Understanding the pathogenesis of ANCA: where are we today?

Authors:  Gloria A Preston; Jia Jin Yang; Hong Xiao; Ronald J Falk
Journal:  Cleve Clin J Med       Date:  2002       Impact factor: 2.321

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury.

Authors:  Minako Nishio; Katsunobu Yoshioka; Keiko Yamagami; Takashi Morikawa; Yoshio Konishi; Noriko Hayashi; Kimihide Himuro; Masahito Imanishi
Journal:  Mod Rheumatol       Date:  2008-04-17       Impact factor: 3.023

5.  Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis.

Authors:  Toshiyuki Ohta; Takashi Sakano; Mami Shiotsu; Takeki Furue; Hideyuki Ohtani; Yoshihisa Kinoshita; Tatsuya Mizoue; Katsuzo Kiya; Issei Tanaka
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

6.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

  6 in total
  7 in total

1.  Posterior reversible encephalopathy syndrome in ANCA-associated vasculitis.

Authors:  Hong-Liang Zhang; Yi Yang; Jiang Wu
Journal:  Rheumatol Int       Date:  2011-07-15       Impact factor: 2.631

Review 2.  Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides.

Authors:  A M Marra; G Barilaro; V Villella; M Granata
Journal:  Rheumatol Int       Date:  2015-04-03       Impact factor: 2.631

3.  The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.

Authors:  Hongtao Hu; Shen Xu; Shuang Hu; Weijia Xu; Hua Shui
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

4.  Fatal hemoperitoneum due to rupture of mesenteric artery in remission state of microscopic polyangiitis, concomitant with severe hypertension and posterior reversible encephalopathy syndrome: an autopsy case report.

Authors:  Aya Nawata; Ayane Nakamura; Masanao Taba; Shumpei Kosaka; Akio Kawabe; Hiroko Miyata; Yasumasa Matsuki; Yoshiya Tanaka; Masanori Hisaoka
Journal:  CEN Case Rep       Date:  2021-05-04

Review 5.  Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know.

Authors:  Yang Zheng; Yinxi Zhang; Mengting Cai; Nanxi Lai; Zhong Chen; Meiping Ding
Journal:  Front Neurol       Date:  2019-01-10       Impact factor: 4.003

6.  Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China.

Authors:  Suying Liu; Ling Guo; Xiaoyuan Fan; Zhaocui Zhang; Jiaxin Zhou; Xinping Tian; Mengtao Li; Xiaofeng Zeng; Li Wang; Fengchun Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-03-31       Impact factor: 4.123

7.  Posterior Reversible Encephalopathy Syndrome in a Patient With Microscopic Polyangiitis: A Case Report and Literature Review.

Authors:  Jing Xu; Ying Ding; Zhen Qu; Feng Yu
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.